Ambusol AB (publ)
559465-8303ActivePioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
Oversikt
- 1–4
- Ansatte
- 100–149t SEK
- Omsetning
- 2023
- Grunnlagt
Nøkkelbeslutningstakere
Göran Ronquist
Founder and board member
Owe Orwar
Senior Adviser to the board
Frederic Telander
Founder and chairman of the board
Holger Ronquist
Founder and board member
+2 flere kontakter i Funnelfeedr
Beskrivelse
Ambusol is a clinical-stage cancer therapeutics company focused on revolutionizing the treatment of glioblastoma (GBM). Their core mission is to eradicate residual GBM cells remaining in the surgical margins after operation, offering new hope to patients. The company pioneers a patented approach uti...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Tillverkning av läkemedel
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559465830301
Beslutningstakere
6 kontakter i FunnelfeedrGöran Ronquist
Founder and board member
Owe Orwar
Senior Adviser to the board
Frederic Telander
Founder and chairman of the board
Holger Ronquist
Founder and board member
Maximilian Telander
CEO, founder and board member
Gunnar Ronquist
Founder and board member
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrIsofol Medical AB (publ)
10–19 ansatteDeveloping next-generation folate drug to improve cancer treatment efficacy.
AcroPharma AB (publ)
0 ansatteDeveloping innovative preventive therapeutics for major human diseases.
Mendus AB (publ)
Developing immune-based cancer therapies to prevent recurrence.
Akiram Therapeutics AB
1–4 ansattePioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
AAX Biotech AB
5–9 ansatteResearch-driven biotech advancing antibody therapies via proprietary technology.
Utforsk mer
Spørsmål om Ambusol AB (publ)
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo